ReP USP - Resultado da busca

Artigo de periodico
Influence of high altitude on the expression of HIF-1 and on the prognosis of Ecuadorian patients with gastric adenocarcinoma (2022)
Barrera, Edwin Cevallos; Martinez, Edson Zangiacomi ; Brunaldi, Mariângela Ottoboni; Donadi, Eduardo Antônio; Sankarankutty, Ajith Kumar ; Kemp, Rafael; Santos, José Sebastião dos
Fonte: Oncotarget. Unidade: FMRP
Assuntos: ADENOCARCINOMA, ESTÔMAGO, NEOPLASIAS, ANÓXIA, ESTUDOS RETROSPECTIVOS, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARRERA, Edwin Cevallos et al. Influence of high altitude on the expression of HIF-1 and on the prognosis of Ecuadorian patients with gastric adenocarcinoma. Oncotarget, v. 13, p. 1043-1053, 2022Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.28275. Acesso em: 14 nov. 2024.
APA
Barrera, E. C., Martinez, E. Z., Brunaldi, M. O., Donadi, E. A., Sankarankutty, A. K., Kemp, R., & Santos, J. S. dos. (2022). Influence of high altitude on the expression of HIF-1 and on the prognosis of Ecuadorian patients with gastric adenocarcinoma. Oncotarget, 13, 1043-1053. doi:10.18632/oncotarget.28275
NLM
Barrera EC, Martinez EZ, Brunaldi MO, Donadi EA, Sankarankutty AK, Kemp R, Santos JS dos. Influence of high altitude on the expression of HIF-1 and on the prognosis of Ecuadorian patients with gastric adenocarcinoma [Internet]. Oncotarget. 2022 ; 13 1043-1053.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.28275
Vancouver
Barrera EC, Martinez EZ, Brunaldi MO, Donadi EA, Sankarankutty AK, Kemp R, Santos JS dos. Influence of high altitude on the expression of HIF-1 and on the prognosis of Ecuadorian patients with gastric adenocarcinoma [Internet]. Oncotarget. 2022 ; 13 1043-1053.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.28275
Artigo de periodico
The role of circulating miRNAs and CA19-9 in pancreatic cancer diagnosis (2021)
Vieira, Nivaldo Faria; Serafini, Luciano Neder; Novais, Paulo Cezar; Lizarte Neto, Fermino Sanches; Cirino, Mucio Luiz de Assis; Kemp, Rafael; Ardengh, José Celso; Saggioro, Fabiano Pinto; Gaspar, Alberto Facury; Sankarankutty, Ajith Kumar ; Lopes Júnior, Jorge Resende; Tirapelli, Daniela Pretti da Cunha; Santos, José Sebastião dos
Fonte: Oncotarget. Unidade: FMRP
Assuntos: BIOMARCADORES, NEOPLASIAS PANCREÁTICAS, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEIRA, Nivaldo Faria et al. The role of circulating miRNAs and CA19-9 in pancreatic cancer diagnosis. Oncotarget, v. 12, n. 17, p. 1638-1650, 2021Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.28038. Acesso em: 14 nov. 2024.
APA
Vieira, N. F., Serafini, L. N., Novais, P. C., Lizarte Neto, F. S., Cirino, M. L. de A., Kemp, R., et al. (2021). The role of circulating miRNAs and CA19-9 in pancreatic cancer diagnosis. Oncotarget, 12( 17), 1638-1650. doi:10.18632/oncotarget.28038
NLM
Vieira NF, Serafini LN, Novais PC, Lizarte Neto FS, Cirino ML de A, Kemp R, Ardengh JC, Saggioro FP, Gaspar AF, Sankarankutty AK, Lopes Júnior JR, Tirapelli DP da C, Santos JS dos. The role of circulating miRNAs and CA19-9 in pancreatic cancer diagnosis [Internet]. Oncotarget. 2021 ; 12( 17): 1638-1650.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.28038
Vancouver
Vieira NF, Serafini LN, Novais PC, Lizarte Neto FS, Cirino ML de A, Kemp R, Ardengh JC, Saggioro FP, Gaspar AF, Sankarankutty AK, Lopes Júnior JR, Tirapelli DP da C, Santos JS dos. The role of circulating miRNAs and CA19-9 in pancreatic cancer diagnosis [Internet]. Oncotarget. 2021 ; 12( 17): 1638-1650.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.28038
Artigo de periodico
Highly expressed placental miRNAs control key biological processes in human cancer cell lines (2018)
Vidal, Daniel Onofre; Ramão, Anelisa ; Pinheiro, Daniel Guariz; Muys, Bruna Rodrigues ; Lorenzi, Julio Cesar Cetrulo; Alves, Cleidson de Pádua; Zanette, Dalila Luciola; Molfetta, Greice Andreotti de ; Duarte, Geraldo ; Silva Junior, Wilson Araújo
Fonte: Oncotarget. Unidade: FMRP
Assuntos: PLACENTA, CARCINOGÊNESE, REGULAÇÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIDAL, Daniel Onofre et al. Highly expressed placental miRNAs control key biological processes in human cancer cell lines. Oncotarget, v. 9, n. 34, p. 23554-23563, 2018Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.25264. Acesso em: 14 nov. 2024.
APA
Vidal, D. O., Ramão, A., Pinheiro, D. G., Muys, B. R., Lorenzi, J. C. C., Alves, C. de P., et al. (2018). Highly expressed placental miRNAs control key biological processes in human cancer cell lines. Oncotarget, 9( 34), 23554-23563. doi:10.18632/oncotarget.25264
NLM
Vidal DO, Ramão A, Pinheiro DG, Muys BR, Lorenzi JCC, Alves C de P, Zanette DL, Molfetta GA de, Duarte G, Silva Junior WA. Highly expressed placental miRNAs control key biological processes in human cancer cell lines [Internet]. Oncotarget. 2018 ; 9( 34): 23554-23563.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.25264
Vancouver
Vidal DO, Ramão A, Pinheiro DG, Muys BR, Lorenzi JCC, Alves C de P, Zanette DL, Molfetta GA de, Duarte G, Silva Junior WA. Highly expressed placental miRNAs control key biological processes in human cancer cell lines [Internet]. Oncotarget. 2018 ; 9( 34): 23554-23563.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.25264
Artigo de periodico
ST2/IL-33 signaling promotes malignant development of experimental squamous cell carcinoma by decreasing NK cells cytotoxicity and modulating the intratumoral cell infiltrate (2018)
Amôr, Nádia Ghinelli ; Oliveira, Carine Ervolino de; Gasparoto, Thaís Helena ; Vilas Boas, Vanessa Garcia ; Perri, Graziela ; Kaneno, Ramon; Lara, Vanessa Soares ; Garlet, Gustavo Pompermaier ; Silva, João Santana da ; Martins, Gislaine Aparecida; Hogaboam, Cory ; Cavassani, Karen Angelica; Campanelli, Ana Paula
Fonte: Oncotarget. Unidades: FOB, FMRP
Assuntos: CARCINOMA DE CÉLULAS ESCAMOSAS, CAMUNDONGOS, INTERLEUCINAS, CARCINÓGENOS QUÍMICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMÔR, Nádia Ghinelli et al. ST2/IL-33 signaling promotes malignant development of experimental squamous cell carcinoma by decreasing NK cells cytotoxicity and modulating the intratumoral cell infiltrate. Oncotarget, v. 9, n. 56, p. 30894-30904, 2018Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.30894. Acesso em: 14 nov. 2024.
APA
Amôr, N. G., Oliveira, C. E. de, Gasparoto, T. H., Vilas Boas, V. G., Perri, G., Kaneno, R., et al. (2018). ST2/IL-33 signaling promotes malignant development of experimental squamous cell carcinoma by decreasing NK cells cytotoxicity and modulating the intratumoral cell infiltrate. Oncotarget, 9( 56), 30894-30904. doi:10.18632/oncotarget.30894
NLM
Amôr NG, Oliveira CE de, Gasparoto TH, Vilas Boas VG, Perri G, Kaneno R, Lara VS, Garlet GP, Silva JS da, Martins GA, Hogaboam C, Cavassani KA, Campanelli AP. ST2/IL-33 signaling promotes malignant development of experimental squamous cell carcinoma by decreasing NK cells cytotoxicity and modulating the intratumoral cell infiltrate [Internet]. Oncotarget. 2018 ; 9( 56): 30894-30904.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.30894
Vancouver
Amôr NG, Oliveira CE de, Gasparoto TH, Vilas Boas VG, Perri G, Kaneno R, Lara VS, Garlet GP, Silva JS da, Martins GA, Hogaboam C, Cavassani KA, Campanelli AP. ST2/IL-33 signaling promotes malignant development of experimental squamous cell carcinoma by decreasing NK cells cytotoxicity and modulating the intratumoral cell infiltrate [Internet]. Oncotarget. 2018 ; 9( 56): 30894-30904.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.30894
Artigo de periodico
Accumulation of prohibitin is a common cellular response to different stressing stimuli and protects melanoma cells from ER stress and chemotherapy-induced cell death (2017)
Tortelli Junior, Tharcisio Citrangulo; Godoy, Lyris Martins Franco de; Souza, Gustavo Antonio de; Bonatto, Diego; Otake, Andreia Hanada; Saito, Renata de Freitas; Rosa, Jose Cesar; Greene, Lewis Joel; Chammas, Roger
Fonte: Oncotarget. Unidades: FMRP, FM
Assuntos: APOPTOSE, NEOPLASIAS CUTÂNEAS, MANIFESTAÇÕES CUTÂNEAS, MELANOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TORTELLI JUNIOR, Tharcisio Citrangulo et al. Accumulation of prohibitin is a common cellular response to different stressing stimuli and protects melanoma cells from ER stress and chemotherapy-induced cell death. Oncotarget, v. 8, n. 26, p. 43114-43129, 2017Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.17810. Acesso em: 14 nov. 2024.
APA
Tortelli Junior, T. C., Godoy, L. M. F. de, Souza, G. A. de, Bonatto, D., Otake, A. H., Saito, R. de F., et al. (2017). Accumulation of prohibitin is a common cellular response to different stressing stimuli and protects melanoma cells from ER stress and chemotherapy-induced cell death. Oncotarget, 8( 26), 43114-43129. doi:10.18632/oncotarget.17810
NLM
Tortelli Junior TC, Godoy LMF de, Souza GA de, Bonatto D, Otake AH, Saito R de F, Rosa JC, Greene LJ, Chammas R. Accumulation of prohibitin is a common cellular response to different stressing stimuli and protects melanoma cells from ER stress and chemotherapy-induced cell death [Internet]. Oncotarget. 2017 ; 8( 26): 43114-43129.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.17810
Vancouver
Tortelli Junior TC, Godoy LMF de, Souza GA de, Bonatto D, Otake AH, Saito R de F, Rosa JC, Greene LJ, Chammas R. Accumulation of prohibitin is a common cellular response to different stressing stimuli and protects melanoma cells from ER stress and chemotherapy-induced cell death [Internet]. Oncotarget. 2017 ; 8( 26): 43114-43129.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.17810
Artigo de periodico
ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype (2017)
Lucena-Araújo, Antonio Roberto; Coelho-Silva, Juan L.; Pereira-Martins, Diego A.; Thomé, Carolina; Scheucher, Priscila S.; Lange, Ana P.; Paiva, Helder H.; Hemmelgarn, Benjamin T.; Morais-Sobral, Mariana C.; Azevedo, Elisa A.; Franca-Neto, Pedro L.; Franca, Rafael F.; Silva, Cleide L.; Krause, Alexandre; Rego, Eduardo Magalhães
Fonte: Oncotarget. Unidade: FMRP
Assuntos: LEUCEMIA, APOPTOSE, TRANSPLANTE DE MEDULA ÓSSEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUCENA-ARAÚJO, Antonio Roberto et al. ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype. Oncotarget, v. 8, n. 5, p. 8475-8483, 2017Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.14295. Acesso em: 14 nov. 2024.
APA
Lucena-Araújo, A. R., Coelho-Silva, J. L., Pereira-Martins, D. A., Thomé, C., Scheucher, P. S., Lange, A. P., et al. (2017). ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype. Oncotarget, 8( 5), 8475-8483. doi:10.18632/oncotarget.14295
NLM
Lucena-Araújo AR, Coelho-Silva JL, Pereira-Martins DA, Thomé C, Scheucher PS, Lange AP, Paiva HH, Hemmelgarn BT, Morais-Sobral MC, Azevedo EA, Franca-Neto PL, Franca RF, Silva CL, Krause A, Rego EM. ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype [Internet]. Oncotarget. 2017 ; 8( 5): 8475-8483.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.14295
Vancouver
Lucena-Araújo AR, Coelho-Silva JL, Pereira-Martins DA, Thomé C, Scheucher PS, Lange AP, Paiva HH, Hemmelgarn BT, Morais-Sobral MC, Azevedo EA, Franca-Neto PL, Franca RF, Silva CL, Krause A, Rego EM. ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype [Internet]. Oncotarget. 2017 ; 8( 5): 8475-8483.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.14295
Artigo de periodico
SIRT1 regulates Mxd1 during malignant melanoma progression (2017)
Meliso, Fabiana M.; Micali, Danilo; Silva, Camila T.; Sabedot, Thaís S.; Coetzee, Simon G.; Koch, Adrian; Fahlbusch, Fabian B.; Noushmehr, Houtan; Schneider-Stock, Regine; Jasiulionis, Miriam G.
Fonte: Oncotarget. Unidade: FMRP
Assuntos: MELANOMA, CITOCINAS, GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MELISO, Fabiana M. et al. SIRT1 regulates Mxd1 during malignant melanoma progression. Oncotarget, v. 8, n. 70, p. 114540-114553, 2017Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.21457. Acesso em: 14 nov. 2024.
APA
Meliso, F. M., Micali, D., Silva, C. T., Sabedot, T. S., Coetzee, S. G., Koch, A., et al. (2017). SIRT1 regulates Mxd1 during malignant melanoma progression. Oncotarget, 8( 70), 114540-114553. doi:10.18632/oncotarget.21457
NLM
Meliso FM, Micali D, Silva CT, Sabedot TS, Coetzee SG, Koch A, Fahlbusch FB, Noushmehr H, Schneider-Stock R, Jasiulionis MG. SIRT1 regulates Mxd1 during malignant melanoma progression [Internet]. Oncotarget. 2017 ; 8( 70): 114540-114553.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.21457
Vancouver
Meliso FM, Micali D, Silva CT, Sabedot TS, Coetzee SG, Koch A, Fahlbusch FB, Noushmehr H, Schneider-Stock R, Jasiulionis MG. SIRT1 regulates Mxd1 during malignant melanoma progression [Internet]. Oncotarget. 2017 ; 8( 70): 114540-114553.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.21457
Artigo de periodico
IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms (2016)
Campos, Paula de Melo; Machado Neto, João Agostinho ; Eide, Christopher A.; Savage, Samantha L.; Scopim-Ribeiro, Renata; Duarte, Adriana da Silva Souza; Favaro, Patrícia; Lorand-Metze, Irene; Costa, Fernando F.; Tognon, Cristina E.; Druker, Brian J.; Saad, Sara T. Olalla; Traina, Fabiola
Fonte: Oncotarget. Unidade: FMRP
Assuntos: REAÇÃO EM CADEIA POR POLIMERASE, APOPTOSE, MUTAÇÃO GENÉTICA, LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOS, Paula de Melo et al. IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms. Oncotarget, v. 7, n. 6, p. 6948-6959, 2016Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.6851. Acesso em: 14 nov. 2024.
APA
Campos, P. de M., Machado Neto, J. A., Eide, C. A., Savage, S. L., Scopim-Ribeiro, R., Duarte, A. da S. S., et al. (2016). IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms. Oncotarget, 7( 6), 6948-6959. doi:10.18632/oncotarget.6851
NLM
Campos P de M, Machado Neto JA, Eide CA, Savage SL, Scopim-Ribeiro R, Duarte A da SS, Favaro P, Lorand-Metze I, Costa FF, Tognon CE, Druker BJ, Saad STO, Traina F. IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms [Internet]. Oncotarget. 2016 ; 7( 6): 6948-6959.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.6851
Vancouver
Campos P de M, Machado Neto JA, Eide CA, Savage SL, Scopim-Ribeiro R, Duarte A da SS, Favaro P, Lorand-Metze I, Costa FF, Tognon CE, Druker BJ, Saad STO, Traina F. IRS2 silencing increases apoptosis and potentiates the effects of ruxolitinib in JAK2V617F-positive myeloproliferative neoplasms [Internet]. Oncotarget. 2016 ; 7( 6): 6948-6959.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.6851
Artigo de periodico
Unraveling the expression of the oncogene YAP1, a Wnt/betacatenin target, in adrenocortical tumors and its association with poor outcome in pediatric patients (2016)
Abduch, Rafael H.; Bueno, Ana Carolina; Leal, Letícia F.; Cavalcanti, Marcelo M.; Gomes, Débora C.; Brandalise, Silvia R.; Masterallo, Maria J.; Yunes, José A.; Martinelli Júnior, Carlos Eduardo; Tone, Luiz Gonzaga; Tucci Júnior, Silvio; Molina, Carlos Augusto Fernandes; Ramalho, Fernando Silva; Moreira, Ayrton Custódio; Cardinalli, Izilda A.; Scrideli, Carlos Alberto; Ramalho, Leandra Naíra Zambelli; Castro, Margaret de; Antonini, Sonir Roberto Rauber
Fonte: Oncotarget. Unidade: FMRP
Assuntos: PROTEÍNAS PROTO-ONCOGÊNICAS, EXPRESSÃO GÊNICA, NEOPLASIAS DO CÓRTEX SUPRARRENAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ABDUCH, Rafael H. et al. Unraveling the expression of the oncogene YAP1, a Wnt/betacatenin target, in adrenocortical tumors and its association with poor outcome in pediatric patients. Oncotarget, v. 7, n. 51, p. 84634-84644, 2016Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.12382. Acesso em: 14 nov. 2024.
APA
Abduch, R. H., Bueno, A. C., Leal, L. F., Cavalcanti, M. M., Gomes, D. C., Brandalise, S. R., et al. (2016). Unraveling the expression of the oncogene YAP1, a Wnt/betacatenin target, in adrenocortical tumors and its association with poor outcome in pediatric patients. Oncotarget, 7( 51), 84634-84644. doi:10.18632/oncotarget.12382
NLM
Abduch RH, Bueno AC, Leal LF, Cavalcanti MM, Gomes DC, Brandalise SR, Masterallo MJ, Yunes JA, Martinelli Júnior CE, Tone LG, Tucci Júnior S, Molina CAF, Ramalho FS, Moreira AC, Cardinalli IA, Scrideli CA, Ramalho LNZ, Castro M de, Antonini SRR. Unraveling the expression of the oncogene YAP1, a Wnt/betacatenin target, in adrenocortical tumors and its association with poor outcome in pediatric patients [Internet]. Oncotarget. 2016 ; 7( 51): 84634-84644.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.12382
Vancouver
Abduch RH, Bueno AC, Leal LF, Cavalcanti MM, Gomes DC, Brandalise SR, Masterallo MJ, Yunes JA, Martinelli Júnior CE, Tone LG, Tucci Júnior S, Molina CAF, Ramalho FS, Moreira AC, Cardinalli IA, Scrideli CA, Ramalho LNZ, Castro M de, Antonini SRR. Unraveling the expression of the oncogene YAP1, a Wnt/betacatenin target, in adrenocortical tumors and its association with poor outcome in pediatric patients [Internet]. Oncotarget. 2016 ; 7( 51): 84634-84644.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.12382
Artigo de periodico
CATS (FAM64A) abnormal expression reduces clonogenicity of hematopoietic cells (2016)
Barbutti, Isabella; Xavier-Ferrucio, Juliana M.; Machado Neto, João Agostinho ; Ricon, Lauremilia; Traina, Fabiola; Bohlander, Stefan K.; Saad, Sara Teresinha Olalla; Archangelo, Leticia Fröhlich
Fonte: Oncotarget. Unidade: FMRP
Assuntos: LEUCEMIA, PROLIFERAÇÃO CELULAR, PROTEÍNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARBUTTI, Isabella et al. CATS (FAM64A) abnormal expression reduces clonogenicity of hematopoietic cells. Oncotarget, v. 7, n. 42, p. 68385-68396, 2016Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.11724. Acesso em: 14 nov. 2024.
APA
Barbutti, I., Xavier-Ferrucio, J. M., Machado Neto, J. A., Ricon, L., Traina, F., Bohlander, S. K., et al. (2016). CATS (FAM64A) abnormal expression reduces clonogenicity of hematopoietic cells. Oncotarget, 7( 42), 68385-68396. doi:10.18632/oncotarget.11724
NLM
Barbutti I, Xavier-Ferrucio JM, Machado Neto JA, Ricon L, Traina F, Bohlander SK, Saad STO, Archangelo LF. CATS (FAM64A) abnormal expression reduces clonogenicity of hematopoietic cells [Internet]. Oncotarget. 2016 ; 7( 42): 68385-68396.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.11724
Vancouver
Barbutti I, Xavier-Ferrucio JM, Machado Neto JA, Ricon L, Traina F, Bohlander SK, Saad STO, Archangelo LF. CATS (FAM64A) abnormal expression reduces clonogenicity of hematopoietic cells [Internet]. Oncotarget. 2016 ; 7( 42): 68385-68396.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.11724
Artigo de periodico
Epithelial cells captured from ductal carcinoma in situ reveal a gene expression signature associated with progression to invasive breast cancer (2016)
Elias, Eliana Vanina; Castro, Nadia Pereira de; Pineda, Paulo Henrique Baldan; Abuázar, Carolina Sens; Osório, Cynthia Aparecida Bueno de Toledo; Pinilla, Mabel Gigliola; Silva, Sabrina Daniela da; Camargo, Anamaria Aranha; Silva Júnior, Wilson Araújo da; Ferreira, Elisa Napolitano e; Brentani, Helena Paula; Carraro, Dirce Maria
Fonte: Oncotarget. Unidades: FMRP, FM
Assuntos: NEOPLASIAS MAMÁRIAS, CARCINOMA DE DUCTOS INFILTRANTE, MARCADOR MOLECULAR, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ELIAS, Eliana Vanina et al. Epithelial cells captured from ductal carcinoma in situ reveal a gene expression signature associated with progression to invasive breast cancer. Oncotarget, v. 7, n. 46, p. 75672-75684, 2016Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.12352. Acesso em: 14 nov. 2024.
APA
Elias, E. V., Castro, N. P. de, Pineda, P. H. B., Abuázar, C. S., Osório, C. A. B. de T., Pinilla, M. G., et al. (2016). Epithelial cells captured from ductal carcinoma in situ reveal a gene expression signature associated with progression to invasive breast cancer. Oncotarget, 7( 46), 75672-75684. doi:10.18632/oncotarget.12352
NLM
Elias EV, Castro NP de, Pineda PHB, Abuázar CS, Osório CAB de T, Pinilla MG, Silva SD da, Camargo AA, Silva Júnior WA da, Ferreira EN e, Brentani HP, Carraro DM. Epithelial cells captured from ductal carcinoma in situ reveal a gene expression signature associated with progression to invasive breast cancer [Internet]. Oncotarget. 2016 ; 7( 46): 75672-75684.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.12352
Vancouver
Elias EV, Castro NP de, Pineda PHB, Abuázar CS, Osório CAB de T, Pinilla MG, Silva SD da, Camargo AA, Silva Júnior WA da, Ferreira EN e, Brentani HP, Carraro DM. Epithelial cells captured from ductal carcinoma in situ reveal a gene expression signature associated with progression to invasive breast cancer [Internet]. Oncotarget. 2016 ; 7( 46): 75672-75684.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.12352
Artigo de periodico
RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma (2016)
Goedert, Lucas; Pereira, Cristiano G.; Roszik, Jason; Plaça, Jessica R.; Cardoso, Cibele; Chen, Guo; Deng, Wanleng; Yennu-Nanda, Vashisht Gopal; Silva Júnior, Wilson Araújo da; Davies, Michael A.; Espreáfico, Enilza Maria
Fonte: Oncotarget. Unidade: FMRP
Assuntos: MELANOMA, RNA, PROLIFERAÇÃO CELULAR, EXPRESSÃO GÊNICA, TERAPÊUTICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOEDERT, Lucas et al. RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma. Oncotarget, v. 7, n. 24, p. 36711-36718, 2016Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.9164. Acesso em: 14 nov. 2024.
APA
Goedert, L., Pereira, C. G., Roszik, J., Plaça, J. R., Cardoso, C., Chen, G., et al. (2016). RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma. Oncotarget, 7( 24), 36711-36718. doi:10.18632/oncotarget.9164
NLM
Goedert L, Pereira CG, Roszik J, Plaça JR, Cardoso C, Chen G, Deng W, Yennu-Nanda VG, Silva Júnior WA da, Davies MA, Espreáfico EM. RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma [Internet]. Oncotarget. 2016 ; 7( 24): 36711-36718.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.9164
Vancouver
Goedert L, Pereira CG, Roszik J, Plaça JR, Cardoso C, Chen G, Deng W, Yennu-Nanda VG, Silva Júnior WA da, Davies MA, Espreáfico EM. RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma [Internet]. Oncotarget. 2016 ; 7( 24): 36711-36718.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.9164
Artigo de periodico
Gene expression patterns through oral squamous cell carcinoma development: PD-L1 expression in primary tumor and circulating tumor cells (2015)
Oliveira-Costa, João Paulo; Carvalho, Alex Fiorini de; Silveira, Giorgia Gobbi da; Amaya, Peter; Wu, Yongqi; Park, Kyoung-Joo Jenny; Gigliola, Mabel Pinilla; Lustberg, Maryam; Buim, Marcilei Eliza Cavicchioli; Ferreira, Elisa Napolitano; Kowalski, Luiz Paulo; Chalmers, Jeffrey J; Soares, Fernando Augusto; Carraro, Dirce Maria; Ribeiro-Silva, Alfredo
Fonte: Oncotarget. Unidade: FMRP
Assuntos: CARCINOMA DE CÉLULAS ESCAMOSAS, NEOPLASIAS BUCAIS, BIOMARCADORES, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA-COSTA, João Paulo et al. Gene expression patterns through oral squamous cell carcinoma development: PD-L1 expression in primary tumor and circulating tumor cells. Oncotarget, v. 6, n. 25, p. 20902-20920, 2015Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.3939. Acesso em: 14 nov. 2024.
APA
Oliveira-Costa, J. P., Carvalho, A. F. de, Silveira, G. G. da, Amaya, P., Wu, Y., Park, K. -J. J., et al. (2015). Gene expression patterns through oral squamous cell carcinoma development: PD-L1 expression in primary tumor and circulating tumor cells. Oncotarget, 6( 25), 20902-20920. doi:10.18632/oncotarget.3939
NLM
Oliveira-Costa JP, Carvalho AF de, Silveira GG da, Amaya P, Wu Y, Park K-JJ, Gigliola MP, Lustberg M, Buim MEC, Ferreira EN, Kowalski LP, Chalmers JJ, Soares FA, Carraro DM, Ribeiro-Silva A. Gene expression patterns through oral squamous cell carcinoma development: PD-L1 expression in primary tumor and circulating tumor cells [Internet]. Oncotarget. 2015 ; 6( 25): 20902-20920.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.3939
Vancouver
Oliveira-Costa JP, Carvalho AF de, Silveira GG da, Amaya P, Wu Y, Park K-JJ, Gigliola MP, Lustberg M, Buim MEC, Ferreira EN, Kowalski LP, Chalmers JJ, Soares FA, Carraro DM, Ribeiro-Silva A. Gene expression patterns through oral squamous cell carcinoma development: PD-L1 expression in primary tumor and circulating tumor cells [Internet]. Oncotarget. 2015 ; 6( 25): 20902-20920.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.3939
Artigo de periodico
Inhibition of the Tcf/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis (2015)
Leal, Letícia F; Bueno, Ana Carolina; Gomes, Débora C; Abduch, Rafael; Castro, Margaret de; Antonini, Sonir Roberto Rauber
Fonte: Oncotarget. Unidade: FMRP
Assuntos: NEOPLASIAS, APOPTOSE, TERAPÊUTICA MÉDICA, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEAL, Letícia F et al. Inhibition of the Tcf/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis. Oncotarget, v. 6, n. 40, p. 43016-43032, 2015Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.5513. Acesso em: 14 nov. 2024.
APA
Leal, L. F., Bueno, A. C., Gomes, D. C., Abduch, R., Castro, M. de, & Antonini, S. R. R. (2015). Inhibition of the Tcf/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis. Oncotarget, 6( 40), 43016-43032. doi:10.18632/oncotarget.5513
NLM
Leal LF, Bueno AC, Gomes DC, Abduch R, Castro M de, Antonini SRR. Inhibition of the Tcf/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis [Internet]. Oncotarget. 2015 ; 6( 40): 43016-43032.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.5513
Vancouver
Leal LF, Bueno AC, Gomes DC, Abduch R, Castro M de, Antonini SRR. Inhibition of the Tcf/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis [Internet]. Oncotarget. 2015 ; 6( 40): 43016-43032.[citado 2024 nov. 14 ] Available from: https://doi.org/10.18632/oncotarget.5513

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada